At the core of anxiety lies a communication imbalance between the amygdala, the brain's threat detection center, and the prefrontal cortex, which normally exerts top-down inhibitory control over fear responses. In individuals with anxiety disorders, the prefrontal cortex's regulatory capacity diminishes while the amygdala becomes hyperactive, producing exaggerated responses to perceived threats that would not typically trigger alarm in a regulated brain.
This neural circuit disruption cascades into measurable neurochemical changes. Dysregulated levels of serotonin, gamma-aminobutyric acid (GABA), and norepinephrine alter the brain's ability to modulate arousal states, leaving the nervous system locked in a heightened "fight-or-flight" mode. Research shows that individuals with generalized anxiety disorder exhibit up to 22% reduced GABA concentrations in key brain regions.
The hypothalamic-pituitary-adrenal (HPA) axis, which governs cortisol production, becomes chronically overactivated in anxiety disorders. Sustained elevated cortisol further impairs prefrontal cortex function and can reduce hippocampal volume over time, compounding difficulties with emotional regulation and memory processing.
